Stock DB DECIBEL CANNABIS COMPANY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Decibel Cannabis Company Inc.

Equities

DB

CA2434371001

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 20:31:03 07/05/2024 BST 		5-day change 1st Jan Change
0.115 CAD -4.17% Intraday chart for Decibel Cannabis Company Inc. -11.54% -11.54%
04-29 Decibel Cannabis Company Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-10 Fire & Flower Inc completed the acquisition of brick and mortar retail cannabis operations of Decibel Cannabis Company Inc.(TSXV:DB). CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 68.5 24.39 58.58 40.45 53.18 49.08 - -
Enterprise Value (EV) 1 68.5 24.39 58.58 40.45 53.18 81.88 72.18 49.08
P/E ratio - -2.33 x 14.5 x -10 x - 4.8 x 2.67 x 3 x
Yield - - - - - - - -
Capitalization / Revenue 11 x - 1.12 x 0.51 x 0.46 x 0.45 x 0.39 x 0.31 x
EV / Revenue 11 x - 1.12 x 0.51 x 0.46 x 0.76 x 0.57 x 0.31 x
EV / EBITDA -38.1 x - 7.9 x 2.38 x 2.05 x 3.71 x 2.52 x 1.2 x
EV / FCF -25.3 x - - - - 31.5 x 7.18 x -
FCF Yield -3.95% - - - - 3.18% 13.9% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 342,504 348,489 403,990 404,484 409,039 409,039 - -
Reference price 2 0.2000 0.0700 0.1450 0.1000 0.1300 0.1200 0.1200 0.1200
Announcement Date 25/05/20 14/04/21 22/04/22 24/04/23 29/04/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6.2 - 52.45 79.33 116 108.3 126.4 157.3
EBITDA 1 -1.8 - 7.417 17.01 25.9 22.07 28.67 41
EBIT 1 -3.647 - 5.968 -0.714 1.412 4.9 19.7 -
Operating Margin -58.82% - 11.38% -0.9% 1.22% 4.53% 15.59% -
Earnings before Tax (EBT) - - 1.743 -4.462 -1.77 - - -
Net income 1 - -9.21 1.743 -4.462 -1.77 9.75 18.6 -
Net margin - - 3.32% -5.62% -1.53% 9.01% 14.72% -
EPS 2 - -0.0300 0.0100 -0.0100 - 0.0250 0.0450 0.0400
Free Cash Flow 1 -2.704 - - - - 2.6 10.05 -
FCF margin -43.61% - - - - 2.4% 7.95% -
FCF Conversion (EBITDA) - - - - - 11.78% 35.06% -
FCF Conversion (Net income) - - - - - 26.67% 54.03% -
Dividend per Share - - - - - - - -
Announcement Date 25/05/20 14/04/21 22/04/22 24/04/23 29/04/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 13.37 14.02 16.65 18.56 18.32 25.8 27.14 30.89 30.19 27.73 23.87 26 28.43 29.93 30
EBITDA 1 2.256 1.45 2.459 3.23 4.259 7.061 6.765 7.302 6.702 5.136 4.167 5.2 6.167 6.533 6.7
EBIT 0.15 1.715 -3.382 -1.199 5.923 -2.055 0.171 - - -0.291 - - - - -
Operating Margin 1.12% 12.23% -20.31% -6.46% 32.33% -7.97% 0.63% - - -1.05% - - - - -
Earnings before Tax (EBT) -0.926 0.667 -4.372 -2.112 5.169 -3.147 -0.569 - - -1.191 - - - - -
Net income -0.913 0.654 -4.372 -2.112 5.169 -3.147 -0.569 - - -1.191 - - - - -
Net margin -6.83% 4.67% -26.26% -11.38% 28.21% -12.2% -2.1% - - -4.29% - - - - -
EPS 2 - 0.0100 -0.0100 -0.0100 0.0100 - -0.001400 - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 18/11/21 22/04/22 25/05/22 18/08/22 15/11/22 24/04/23 29/05/23 29/10/23 16/11/23 29/04/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 32.8 23.1 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - - 1.486 x 0.8058 x -
Free Cash Flow 1 -2.7 - - - - 2.6 10.1 -
ROE (net income / shareholders' equity) - - - - - 12.8% 13.9% -
ROA (Net income/ Total Assets) - - - - - 5.1% 6.5% -
Assets 1 - - - - - 191.2 286.2 -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 1.26 - - - - 2 3.5 -
Capex / Sales 20.32% - - - - 1.85% 2.77% -
Announcement Date 25/05/20 14/04/21 22/04/22 24/04/23 29/04/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Decibel Cannabis Company Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.12 CAD
Average target price
0.3833 CAD
Spread / Average Target
+219.44%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
DECIBEL CANNABIS COMPANY INC. Stock Decibel Cannabis Company Inc.
-11.54% 35.93M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.96% 6.32B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.56% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.52% 3.3B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.47% 3.19B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.76% 2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+56.34% 2.05B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.11% 1.77B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+2.93% 1.7B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.02% 1.63B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. DB Stock
  4. Financials Decibel Cannabis Company Inc.